- Home
- CMPX vs ORIS Comparison
CMPX vs ORIS Comparison
Compare CMPX & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ORIS
- Stock Information
- Founded
- CMPX 2014
- ORIS 2014
- Country
- CMPX United States
- ORIS China
- Employees
- CMPX N/A
- ORIS N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- CMPX Health Care
- ORIS Consumer Staples
- Exchange
- CMPX Nasdaq
- ORIS Nasdaq
- Market Cap
- CMPX 206.3M
- ORIS 182.0M
- IPO Year
- CMPX N/A
- ORIS 2024
- Fundamental
- Price
- CMPX $1.42
- ORIS $1.37
- Analyst Decision
- CMPX Strong Buy
- ORIS
- Analyst Count
- CMPX 3
- ORIS 0
- Target Price
- CMPX $7.67
- ORIS N/A
- AVG Volume (30 Days)
- CMPX 421.2K
- ORIS 2.5M
- Earning Date
- CMPX 11-12-2024
- ORIS 12-31-2024
- Dividend Yield
- CMPX N/A
- ORIS N/A
- EPS Growth
- CMPX N/A
- ORIS N/A
- EPS
- CMPX N/A
- ORIS 0.96
- Revenue
- CMPX $850,000.00
- ORIS $24,122,000.00
- Revenue This Year
- CMPX N/A
- ORIS N/A
- Revenue Next Year
- CMPX $610.48
- ORIS N/A
- P/E Ratio
- CMPX N/A
- ORIS $1.52
- Revenue Growth
- CMPX N/A
- ORIS N/A
- 52 Week Low
- CMPX $0.77
- ORIS $1.22
- 52 Week High
- CMPX $2.34
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- CMPX 41.28
- ORIS N/A
- Support Level
- CMPX $1.44
- ORIS N/A
- Resistance Level
- CMPX $1.58
- ORIS N/A
- Average True Range (ATR)
- CMPX 0.12
- ORIS 0.00
- MACD
- CMPX -0.01
- ORIS 0.00
- Stochastic Oscillator
- CMPX 11.63
- ORIS 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.